A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION

Clinical trial NCT00759174 · COMPLETED

Trial details

NCT number: NCT00759174
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Optic Neuropathy, Ischemic

Start date: 2008-11-01
Primary completion: 2012-10-01
Enrollment: 673

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.